114 related articles for article (PubMed ID: 9063542)
1. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate.
Linakis JG; Hull KM; Lacouture PG; Lockhart GR; Lewander WJ; Maher TJ
Acad Emerg Med; 1997 Mar; 4(3):175-8. PubMed ID: 9063542
[TBL] [Abstract][Full Text] [Related]
2. Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice.
Linakis JG; Hull KM; Lee CM; Maher TJ; Lewander WJ; Lacouture PG
Acad Emerg Med; 1995 Aug; 2(8):681-5. PubMed ID: 7584745
[TBL] [Abstract][Full Text] [Related]
3. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model.
Linakis JG; Eisenberg MS; Lacouture PG; Maher TJ; Lewander WJ; Driscoll JL; Woolf A
Pharmacol Toxicol; 1992 Jan; 70(1):38-40. PubMed ID: 1594533
[TBL] [Abstract][Full Text] [Related]
4. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model.
Linakis JG; Lacouture PG; Eisenberg MS; Maher TJ; Lewander WJ; Driscoll JL; Woolf AD
Pharmacol Toxicol; 1989 Nov; 65(5):387-9. PubMed ID: 2622869
[TBL] [Abstract][Full Text] [Related]
5. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations.
Linakis JG; Hull KM; Lacouture PG; Lockhart GR; Lewander WJ; Maher TJ
Acad Emerg Med; 1996 Apr; 3(4):333-7. PubMed ID: 8881542
[TBL] [Abstract][Full Text] [Related]
6. Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice.
Linakis JG; Savitt DL; Wu TY; Lockhart GR; Lacouture PG
J Toxicol Clin Toxicol; 1998; 36(4):309-13. PubMed ID: 9711196
[TBL] [Abstract][Full Text] [Related]
7. Potassium repletion fails to interfere with reduction of serum lithium by sodium polystyrene sulfonate in mice.
Linakis JG; Savitt DL; Trainor BJ; Young JE; Lacouture PG
Acad Emerg Med; 2001 Oct; 8(10):956-60. PubMed ID: 11581080
[TBL] [Abstract][Full Text] [Related]
8. Use of sodium polystyrene sulfonate in a lithium overdose.
Roberge RJ; Martin TG; Schneider SM
Ann Emerg Med; 1993 Dec; 22(12):1911-5. PubMed ID: 8239115
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
Mistry M; Shea A; Giguère P; Nguyen ML
Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study.
Ghannoum M; Lavergne V; Yue CS; Ayoub P; Perreault MM; Roy L
Clin Toxicol (Phila); 2010 Jan; 48(1):34-41. PubMed ID: 19842945
[TBL] [Abstract][Full Text] [Related]
11. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers.
Tomaszewski C; Musso C; Pearson JR; Kulig K; Marx JA
Ann Emerg Med; 1992 Nov; 21(11):1308-11. PubMed ID: 1416323
[TBL] [Abstract][Full Text] [Related]
12. In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
Gehrke JC; Watling SM; Gehrke CW; Zumwalt R
Am J Emerg Med; 1996 Jan; 14(1):37-8. PubMed ID: 8630152
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
Lee J; Moffett BS
Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
[TBL] [Abstract][Full Text] [Related]
15. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
Watling SM; Gehrke JC; Gehrke CW; Zumwalt R; Pribble J
Am J Emerg Med; 1995 May; 13(3):294-6. PubMed ID: 7755820
[TBL] [Abstract][Full Text] [Related]
16. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
[TBL] [Abstract][Full Text] [Related]
17. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
Hagan AE; Farrington CA; Wall GC; Belz MM
Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
[TBL] [Abstract][Full Text] [Related]
18. Lithium concentrations in saliva, plasma and red blood cells of patients given lithium acetate.
Evrard JL; Baumann P; Pera-Bally R; Peters-Haefeli L
Acta Psychiatr Scand; 1978 Jul; 58(1):67-79. PubMed ID: 696379
[TBL] [Abstract][Full Text] [Related]
19. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
Kessler C; Ng J; Valdez K; Xie H; Geiger B
J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
